Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARAMIS: Anakinra in Acute Myocarditis
NCT03018834Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2017
- Primary completion
- Jun 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute myocarditis comparing A: ANAKINRA with B: Placebo (2 arms). Primary endpoint: Number of days alive free of any myocarditis complications at 28 days. Started May 2017; status: completed.
02
Drugs
anakinra
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT03018834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018834.